. 2016 Nov 1;10(11):QC08–QC10. doi: 10.7860/JCDR/2016/19375.8937

[Table/Fig-2]:

Mean Hb at 1 week and 6 weeks and mean rise of Hb from the start of treatment.

BCC subtype	Group N=45	Mean	Std. Deviation	p-value
Hb at the start of treatment (g/dl)	FCM	8.710	0.835	p=0.206 ns
Hb at the start of treatment (g/dl)	Oral iron	8.907	0.617	p=0.206 ns
Hb after 1 week of start of treatment (g/dl)	FCM	10.688	0.980	p<.001 hs
Hb after 1 week of start of treatment (g/dl)	Oral iron	10.044	0.750	p<.001 hs
Hb after 6 weeks of start of treatment (g/dl)	FCM	11.938	0.874	p<0.001 hs
Hb after 6 weeks of start of treatment (g/dl)	Oral iron	11.156	0.744	p<0.001 hs
Mean rise in Hb at 1 week	FCM	1.980	0.844	p<0.001 hs
Mean rise in Hb at 1 week	Oral iron	1.138	0.669	p<0.001 hs
Mean rise in HB at 6 weeks	FCM	3.227	1.242	p<0.001 hs
Mean rise in HB at 6 weeks	Oral iron	2.271	0.711	p<0.001 hs

p-value of <0.05 is considered significant; hs- highly significant